Текст книги "В постели с бактериями. История, наука и секреты микроскопических существ, о которых не принято говорить"
Автор книги: Айна Парк
сообщить о нарушении
Текущая страница: 22 (всего у книги 23 страниц)
17. Worobey M., Gemmel M., Teuwen D. E., Haselkorn T., Kunstman K., Bunce M., Muyembe J. J., Kabongo J. M., Kalengayi R. M., Van Marck E., Gilbert M. T., Wolinsky S. M. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008 Oct 2;455(7213):661–4.
18. Barabási A. L. Linked: How Everything Is Connected to Everything Else and What It Means for Business, Science, and Everyday Life. New York: Penguin; 2003.
19. Kohn R., Fann C., Bernstein K., Philip S. Discovery of a large sexual network using routine partner services data, San Francisco, 2013. Presented at 2014 Centers for Disease Control and Prevention STD Prevention Conference, Atlanta, Georgia.
ГЛАВА ШЕСТАЯ. ТУК-ТУК, ЭТО СЕКС-ПОЛИЦИЯ
1. Potterat J. J. Seeking the Positives: A Life Spent on the Cutting Edge of Public Health. North Charleston, SC: CreateSpace, 2015.
2. Potterat J. J., Spencer N. E., Muth S. Q., eds. In the Shadow of Venus: Vignettes from the Venereal World. North Charleston, SC: CreateSpace, 2017.
3. Healy R. The AIDS tracers. Life. October 1987:52–5.
4. D’Souza G., Cullen K., Bowie J., Thorpe R., Fakhry C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. Liu X., ed. PLOS ONE. 2014;9(1):e86023.
5. Bayer R., Toomey K. E. Health law and ethics: HIV prevention and the two faces of partner notification. Am J Public Health. 1992;82:1158–64.
6. Rutherford G. W., Woo J. M. Contact tracing and the control of human immunodeficiency virus infection. JAMA. 1988; 259:3609–10.
7. Potterat J. J. Contact tracing’s price is not its value. Sex Transm Dis. 1997 Oct;24(9):519–21.
8. Potterat J. J. Disease intervention specialists as a corps, not corpse. Sex Transm Dis. 2008;35(7):703.
9. Potterat J. J. Partner notification for HIV: running out of excuses. Sex Transm Dis. 2003 Jan;30(1):89–90.
10. Golden M. R., Hogben M., Handsfield H. H., St Lawrence J. S., Potterat J. J., Holmes K. K. Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis. 2003 Jun;30(6):490–6.
11. Golden M. R., Hogben M., Potterat J. J., Handsfield H. H. HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis. 2004 Dec;31(12):709–12.
12. Klausner J. Tracking a syphilis outbreak through cyberspace. In: Dworkin M., ed. Outbreak Investigations Around the World: Case Studies in Infectious Disease Field Epidemiology. Burlington, MA: Jones and Bartlett; 2010.
13. Klausner J. D., Wolf W., Fischer-Ponce L., Zolt I., Katz M. H. Tracing a syphilis outbreak through cyberspace. JAMA. 2000;284(4):447–9.
14. Nieves E. Privacy questions raised in cases of syphilis linked to chat room. New York Times. August 25, 1999:A1.
15. Torrone, E. Личное общение, 4 сентября 2020.
16. Pew Research Center. Mobile fact sheet. Available at: http://www.pewinternet.org/fact-sheet/mobile/. Accessed July 8, 2018.
17. Smith C. 50 interesting Tinder statistics and facts (September 2018) | by the numbers. Available at: https://expandedramblings.com/index.php/tinder-statistics/. Accessed September 14, 2018.
18. Johnson K. What is Grindr? Everything you need to know about the gay and bisexual dating app. Available at: https://www.leeds-live.co.uk/news/uk-world-news/grindr-app-dating-gay-bisexual-14662617. Accessed September 14, 2018.
19. Kachur R., Strona F. V., Kinsey J., Collins D. Introducing Technology Into Partner Services: A Toolkit for Programs. Atlanta, GA: Centers for Disease Control and Prevention; 2015.
20. Katz D., Goyette M., Fredericksen R., Wohlfeiler D., Hecht J., Kachur R., Strona F. Acceptability of HIV/STD partner notification using geosocial networking apps. Presented at 2018 STD Prevention Conference, Washington, D. C. Abstract POS 295.
21. Chew Ng R., Nguyen R., Kohn R., Shaw R., Sachdev D., Cohen S., Philip S. Reframing the value of syphilis partner services – San Francisco 2017. Presented at: 2018 STD Prevention Conference, Washington, D. C. Abstract 6C2.
22. Ferreira A., Young T., Mathews C., Zunza M., Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev. 2013 Oct 3;(10):CD002843.
ГЛАВА СЕДЬМАЯ. СИФИЛИС НА ОБА ВАШИХ ДОМА
1. Frith J. Syphilis – its early history and treatment until penicillin and the debate on its origins. J Mil Veterans Health. 2012; 20(4):49–59.
2. Arrizabalaga J., Henderson J., French R. The Great Pox: The French Disease in Renaissance Europe. New Haven, CT: Yale University Press; 2014.
3. Silverman M. E., Murray T. J., Bryan C. S., eds. The Quotable Osler. Philadelphia: American College of Physicians; 2008.
4. Osler W. The campaign against venereal disease: Sir William Osler’s oration. Br Med J. 1917;1(2943):694–6.
5. Brandt A. M. No Magic Bullet: A Social History of Venereal Disease in the United States Since 1880. New York: Oxford University Press; 1985.
6. Ward D. The geography of the Ladies’ Home Journal—an analysis of a magazine’s audience, 1911–1955. J Hist. 2008;34(1):2–14.
7. Parran T. Shadow on the Land. New York: Reynal and Hitchcock; 1937.
8. Livingood C. S. History of the American Board of Dermatology, Inc. (1932–1982). J Am Acad Dermatol. 1982 Dec;7(6):821–50.
9. Nelson N. The civilian education program in the control of syphilis. JAMA. 1936;107(11):872–4.
10. Keating P. Bluff Your Way in Doctoring. Horsham, UK: Ravette; 1993.
11. Wear J., Holmes K. K. How to Have Intercourse Without Getting Screwed. Seattle, WA: Madrona; 1976.
12. Centers for Disease Control and Prevention. Primary and secondary syphilis – United States 2000–2001. MMWR. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5143a4.htm.
13. Centers for Disease Control and Prevention. 2018 STD surveillance: syphilis. Available at: https://www.cdc.gov/std/stats18/syphilis.htm. Accessed June 8, 2020.
14. Williams L. A., Klausner J. D., Whittington W. L., Handsfield H. H., Celum C., Holmes K. K. Elimination and reintroduction of primary and secondary syphilis. Am J Public Health. 1999 Jul;89(7):1093–7.
15. Gage S. H. Dark-field microscopy and the history of its development. Trans Am Microsc Soc. 1920 Apr;39(2):95–141. Available at: https://www.jstor.org/stable/3221838. Accessed January 1, 2019.
16. Dowell D., Polgreen P. M., Beekmann S. E., Workowski K. A., Berman S. M., Peterman T. A. Dilemmas in the management of syphilis: a survey of infectious diseases experts. Clin Infect Dis. 2009 Nov 15;49(10):1526–9.
17. Turner T. B., Hardy P. H., Newman B. Infectivity tests in syphilis. Br J Vener Dis. 1969 Sep;45(3):183–95. PubMed PMID: 4899592; PubMed Central PMCID: PMC1048462.
18. Lukehart S. A. Biology of treponemes. In Holmes K.K et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill; 2008.
19. Hayden D. Pox: Genius, Madness, and the Mysteries of Syphilis. New York: Basic Books; 2003.
20. Pathela P., Braunstein S. L., Blank S., Shepard C., Schillinger J. A. The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men. Clin Infect Dis. 2015 Jul 15;61(2):281–7.
21. Rodriguez R. Fresno County 2017 crop values rebound, rising to $7 billion. Fresno Bee. August 21, 2018. Available at: https://www.fresnobee.com/latest-news/article217097230.html. Accessed January 28, 2019.
22. American Fact Finder. Community facts – San Francisco, California. Available at: https://factfinder.census.gov/faces/nav/jsf/pages/communityfacts.xhtml?src=bkmk. Accessed February 3, 2019.
23. California Department of Public Health, STD Control Branch. California STD data tables 2013–2017. Available at: https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/CA-STD-2017-Data-Tables.pdf.Accessed February 20, 2019.
24. Jones J. H. Bad Blood: The Tuskegee Syphilis Experiment. New York: Free Press; 1993.
25. Heller J. Syphilis victims in U.S. study went untreated for 40 years. New York Times. July 26, 1972. Available at: https://www.nytimes.com/1972/07/26/archives/syphilis-victims-in-us-study-went-untreated-for-40-years-syphilis.html. Accessed January 18, 2019.
26. Katz R. V., Warren R. C., eds. The Search for the Legacy of the USPHS Syphilis Study at Tuskegee. Lanham, MD: Lexington Books; 2011.
27. Katz R. V., Kegeles S. S., Green B. L., Kressin N. R., James S. A., Claudio C. The Tuskegee Legacy Project: history, preliminary scientific findings, and unanticipated societal benefits. Dent Clin North Am. 2003 Jan;47(1):1–19.
28. White House Office of the Press Secretary. Remarks by the president in apology for study done in Tuskegee. May 16, 1997. Available at: https://www.cdc.gov/tuskegee/clintonp.htm. Accessed January 16, 2019.
29. Katz R. V., Green B. L., Kressin N. R., James S. A., Wang M. Q., Claudio C., Russell S. L. Exploring the “legacy” of the Tuskegee Syphilis Study: a follow-up study from the Tuskegee Legacy Project. J Natl Med Assoc. 2009 Feb;101 (2):179–83.
30. Katz R. V., Kegeles S. S., Kressin N. R., Green B. L., James S. A., Wang M. Q., Russell S. L., Claudio C. Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am J Public Health. 2008 Jun;98(6):1137–42.
31. Centers for Disease Control and Prevention. U.S. Public Health Service Syphilis Study at Tuskegee – frequently asked questions. Available at: https://www.cdc.gov/tuskegee/faq.htm. Accessed February 25, 2019.
ГЛАВА ВОСЬМАЯ. ПУТЬ НАИМЕНЬШЕГО СОПРОТИВЛЕНИЯ
1. Wuebker E. Venereal disease visual history archive. Available at: https://vdarchive.newmedialab.cuny.edu/items/browse?collection=9. Accessed March 2, 2019.
2. Rasnake M. S., Conger N. G., McAllister K., Holmes K. K., Tramont E. C. History of U.S. military contributions to the study of sexually transmitted diseases. Mil Med. 2005 Apr;170(4 Suppl):61–5. PubMed PMID: 15916284.
3. Cutler J. C. Gonorrheal Experiment #4. National Archives, records of Dr. John C. Cutler. Available at: https://nara-media-001.s3.amazonaws.com/arcmedia/research/health/cdc-cutler-records/folder-33-gonorrheal-experiment.pdf. Accessed March 18, 2019.
4. Cutler J. C. Experimental studies in gonorrhea. Report. National Archives, records of Dr. John C. Cutler. Available at: https://nara-media-001.s3.amazonaws.com/arcmedia/research/health/cdc-cutler-records/folder-15-experimental-studies-in-gonorrhea.pdf. Accessed March 18, 2019.
5. Semeniuk I., Reverby S. A shocking discovery. Nature. 2010 Oct 7;467 (7316):645.
6. Presidential Commission for the Study of Bioethical Issues. Ethically Impossible: STD Research in Guatemala from 1946 to 1948. Washington, D. C.; 2011. Available at: https://bioethicsarchive.georgetown.edu/pcsbi/sites/default/files/Ethically%20Impossible%20(with%20linked%20historical%20documents)%202.7.13.pdf. Accessed March 2, 2019.
7. Zenilman J. The Guatemala sexually transmitted disease studies: what happened. Sex Transm Dis. 2013 Apr;40(4):277–9.
8. Castillo M. U.S. Rejects Guatemalans’ STD lawsuit, offers aid. CNN. January 10, 2012. Available at: https://www.cnn.com/2012/01/10/world/americas/us-guatemala-std-experiments/index.html. Accessed March 2, 2019.
9. United States Department of State. Tort claims against the U.S. Department of State. Available at: https://www.state.gov/s/l/3202.htm. Accessed March 2, 2019.
10. Stempel J. Johns Hopkins, Bristol-Myers must face $1B in syphilis infections lawsuit. Reuters Health Information. Available at: https://www.reuters.com/article/us-maryland-lawsuit-infections/johns-hopkins-bristol-myers-must-face-1-billion-syphilis-infections-suit-idUSKCN1OY1N3. Accessed January 19, 2019.
11. Philippines Statistics Authority. 2010 population of Olongapo City is twice its population forty years ago. July 10, 2013. Available at: https://psa.gov.ph/content/2010-population-olongapo-city-twice-its-population-forty-years-ago-results-2010-census. Accessed March 19, 2019.
12. Hawaii Tourism Authority. News release HTA: Hawaii visitor statistics released for 2018. Available at: https://governor.hawaii.gov/newsroom/latest-news/news-release-hta-hawaii-visitor-statistics-released-for-2018/. Accessed March 29, 2019.
13. Centers for Disease Control and Prevention. STD success stories: battling antibiotic-resistant gonorrhea: a timeline of coordinated teamwork. Available at: https://www.cdc.gov/std/products/success/Hawaii-SUCCESS-STORIES.pdf. Accessed March 21, 2019.
14. Unemo M., Shafer W. M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. CMR. Jun 2014;27(3):587–613.
15. Elwell L.P., Roberts M., Mayer L.W., Falkow S. Plasmid-mediated beta-lactamase production in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1977 Mar;11(3):528–33.
16. Barbee L. A. Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014 Jun;27(3):282–7.
17. Habel, Melissa A., Jami S. Leichliter, Patricia J. Dittus, Ian H. Spicknall, and Sevgi O. Aral. 2018. “Heterosexual Anal and Oral Sex in Adolescents and Adults in the United States, 2011–2015.” Sexually Transmitted Diseases 45 (12): 775–782.
18. Chow E. P., Howden B. P., Walker S., Lee D., Bradshaw C. S., Chen M. Y., Snow A., Cook S., Fehler G., Fairley C. K. Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomised controlled trial and an in vitro study. Sex Transm Infect. 2017 Mar;93(2):88–93.
19. Emen8. Have we found a new weapon in the fight against gonorrhea? Available at: https://emen8.com.au/health/fitnessandbody/have-we-found-a-new-weapon-in-the-fight-against-gonorrhea/. Accessed March 29, 2019.
20. Sentencing Project. Criminal justice facts. Available at: https://www.sentencingproject.org/criminal-justice-facts/. Accessed March 29, 2019.
21. Thomas J. C., Sampson L. A. High rates of incarceration as a social force associated with community rates of sexually transmitted infection. J Infect Dis. 2005 Feb 1;191 Suppl 1:S55–60.
22. Aral S. O., Hughes J. P., Stoner B., et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health. 1999;89(6):825–833.
23. Andrasik M. P., Nguyen H. V., George W. H., Kajumulo K. F. Sexual decision making in the absence of choice: the African American female dating experience. J Health Dispar Res Pract. 2014 Winter;7(7):66–86.
24. Dauria E. F., Elifson K., Arriola K. J., Wingood G., Cooper H. L.. Male incarceration rates and rates of sexually transmitted infections: results from a longitudinal analysis in a southeastern US city. Sex Transm Dis. 2015 Jun;42(6):324–8.
25. Dauria E.F., Oakley L., Arriola K. J., Elifson K., Wingood G., Cooper H. L. Collateral consequences: implications of male incarceration rates, imbalanced sex ratios and partner availability for heterosexual Black women. Cult Health Sex. 2015;17(10):1190–206.
26. Centers for Disease Control and Prevention. STDs in racial and ethnic minorities. Available at: https://www.cdc.gov/std/stats17/minorities.htm. Accessed March 28, 2019.
27. Potterat J. J, Rothenberg R. B., Woodhouse D. E., Muth J. B., Pratts C. I., Fogle J. S. 2nd. Gonorrhea as a social disease. Sex Transm Dis. 1985 Jan-Mar; 12(1):25–32.
28. Potterat J. J. “Socio-geographic” space and sexually transmissible diseases in the 1990s. Today’s Life Science. 1992; 4 (12); 16–22, 31.
ГЛАВА ДЕВЯТАЯ. ДОКОПАТЬСЯ ДО ПРАВДЫ
1. Enovid advertisement. Can Medical J. 17 February 1962;353.
2. Eig J. The Birth of the Pill: How Four Crusaders Reinvented Sex and Launched a Revolution. New York: W. W. Norton; 2014.
3. The pill: how is it affecting U.S. morals, family life? U.S. News & World Report. July 11, 1966.
4. Myers J. E., Sepkowitz K. A. A pill for HIV prevention: déjа vu all over again? Clin Infect Dis. 2013 Jun;56(11):1604–12. doi: 10.1093/cid/cit085. Epub 2013 Feb 13.
5. Grant R. M., Lama J. R., Anderson P. L., McMahan V., Liu A. Y., Vargas L., Goicochea P., Casapia M., Guanira-Carranza J. V., Ramirez-Cardich M. E., Montoya-Herrera O., Fernández T., Veloso V. G., Buchbinder S. P., Chariyalertsak S., Schechter M., Bekker L. G., Mayer K. H., Kallás E. G., Amico K. R., Mulligan K., Bushman L. R., Hance R. J., Ganoza C., Defechereux P., Postle B., Wang F., McConnell J. J., Zheng J. H., Lee J., Rooney J. F., Jaffe H. S., Martinez A. I., Burns D. N., Glidden D. V.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587–99.
6. Baeten J. M., Donnell D., Ndase P., Mugo N. R., Campbell J. D., Wangisi J., Tappero J. W., Bukusi E. A., Cohen C. R., Katabira E., Ronald A., Tumwesigye E., Were E., Fife K. H., Kiarie J., Farquhar C., John-Stewart G., Kakia A., Odoyo J., Mucunguzi A., Nakku-Joloba E., Twesigye R., Ngure K., Apaka C., Tamooh H., Gabona F., Mujugira A., Panteleeff D., Thomas K. K., Kidoguchi L., Krows M., Revall J., Morrison S., Haugen H., Emmanuel-Ogier M., Ondrejcek L., Coombs R. W., Frenkel L., Hendrix C., Bumpus N. N., Bangsberg D., Haberer J. E., Stevens W. S., Lingappa J. R., Celum C.; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399–410.
7. Duran D. Truvada whores? Huffington Post. November 12, 2012. Updated February 2, 2016. Accessed September 10, 2017. Available at: https://www.huffpost.com/entry/truvada-whoresb2113588.
8. U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection the United States—2014. Available at: https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed September 1, 2017.
9. Smith D. K., Van Handel M., Wolitski R. J., Stryker J. E., Hall H. I., Prejean J., Koenig L. J., Valleroy L. A.. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition – United States, 2015. MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291–5.
10. AIDS Healthcare Foundation. PrEP: the revolution that didn’t happen. Available at: https://www.aidshealth.org/#/archives/24286. Accessed June 8, 2017.
11. Centers for Disease Control and Prevention. HIV among gay and bisexual men. https://www.cdc.gov/hiv/group/msm/index.html. Accessed March 7, 2020.
12. Marrazzo J. M., Ramjee G., Richardson B. A., Gomez K., Mgodi N., Nair G., Palanee T., Nakabiito C., van der Straten A., Noguchi L., Hendrix C. W., Dai J. Y., Ganesh S., Mkhize B., Taljaard M., Parikh U. M., Piper J., Mâsse B., Grossman C., Rooney J., Schwartz J. L.,Watts H., Marzinke M. A., Hillier S. L., McGowan I. M., Chirenje Z. M.; VOICE Study Team. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015 Feb 5;372(6):509–18.
13. van der Straten A., Stadler J., Montgomery E., Hartmann M., Magazi B., Mathebula F., Schwartz K… Laborde N., Soto-Torres L. Women’s Experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLOS ONE. 2014 Feb 21;9(2):e89118.
14. van der Straten A., Montgomery E.T., Musara P., Etima J., Naidoo S., Laborde N., Hartmann M., Levy L., Bennie T., Cheng H., Piper J., Grossman C.I., Marrazzo J., Mensch B.; Microbicide Trials Network-003D Study Team. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015 Oct 23;29(16):2161–71.
15. Centers for Disease Control and Prevention. HIV risk and prevention estimates. Available at: https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html. Accessed August 30, 2017.
16. Cohen M. S., Chen Y. Q., McCauley M., Gamble T., Hosseinipour M. C., Kumarasamy N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H., Godbole S. V., Mehendale S., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Wang L., Makhema J., Mills L. A., de Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T. E., Nielsen-Saines K., Celentano D., Essex M., Fleming T. R.; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505.
17. Cohen M. S., Chen Y. Q., McCauley M., Gamble T., Hosseinipour M. C., Kumarasamy N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H., Godbole S. V., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Cottle L., Zhang X. C., Makhema J., Mills L. A., Panchia R., Faesen S., Eron J., Gallant J., Havlir D., Swindells S., Elharrar V., Burns D., Taha T. E., Nielsen-Saines K., Celentano D. D., Essex M., Hudelson S. E., Redd A. D., Fleming T. R.; HPTN 052 Study Team. Antiretroviral therapy for the prevention of hiv-1 transmission. N Engl J Med. 2016 Sep 1;375(9):830–9.
18. Bavinton B. R., Pinto A. N., Phanuphak N., Grinsztejn B., Prestage G. P., Zablotska-Manos I. B., Jin F., Fairley C. K., Moore R., Roth N., Bloch M., Pell C., McNulty A. M., Baker D., Hoy J., Tee B. K., Templeton D. J., Cooper D. A., Emery S., Kelleher A., Grulich A. E.; Opposites Attract Study Group. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018 Aug;5(8):e438–47.
19. Rodger A. J., Cambiano V., Bruun T., Vernazza P., Collins S., van Lunzen J., Corbelli G. M., Estrada V., Geretti A. M., Beloukas A., Asboe D., Viciana P., Gutiérrez F., Clotet B., Pradier C., Gerstoft J., Weber R., Westling K., Wandeler G., Prins J. M., Rieger A., Stoeckle M., Kümmerle T., Bini T., Ammassari A., Gilson R., Krznaric I., Ristola M., Zangerle R., Handberg P., Antela A., Allan S., Phillips A. N., Lundgren J.; PARTNER Study Group. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the hiv-positive partner is using suppressive antiretroviral therapy. JAMA. 2016 Jul 12;316(2):171–81. doi: 10.1001/jama.2016.5148. Erratum in: JAMA. 2016 Aug 9;316(6):667. JAMA. 2016 Nov 15;316(19):2048.
20. Rodger A. J., Cambiano V., Bruun T., Vernazza P., Collins S., Degen O., Corbelli G. M., Estrada V., Geretti A. M., Beloukas A., Raben D., Coll P., Antinori A., Nwokolo N., Rieger A., Prins J. M., Blaxhult A., Weber R., Van Eeden A., Brockmeyer N. H., Clarke A., Del Romero Guerrero J., Raffi F., Bogner J. R., Wandeler G., Gerstoft J., Gutiérrez F., Brinkman K., Kitchen M., Ostergaard L., Leon A., Ristola M., Jessen H., Stellbrink H. J., Phillips A. N., Lundgren J.; PARTNER Study Group. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019 Jun 15;393(10189):2428–38.
21. Finlayson T., Cha S., Xia M., et al. Changes in HIV Preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. MMWR Morb Mortal Wkly Rep. 2019;68:597–603.
ГЛАВА ДЕСЯТАЯ. ИСПЫТАНИЯ НА ПРОЧНОСТЬ
1. Farrington E. M., Bell D. C., DiBacco A. E. Reasons people give for using (or not using) condoms. AIDS Behav. 2016 Dec;20(12):2850–62.
2. Daniels K., Abma J. C. Current contraceptive status among women aged 15–49: United States, 2015–2017. Available at: https://www.cdc.gov/nchs/data/databriefs/db327-h.pdf. Accessed May 22, 2019.
3. Kann L., McManus T., Harris W. A., et al. Youth Risk Behavior Surveillance – United States, 2017. MMWR Surveill Summ. 2018;67(No. SS-8):1–114.
4. United Nations, Department of Economic and Social Affairs, Population Division (2015). Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349).
5. Yoshida H., Sakamoto H., Leslie A., Takahashi O., Tsuboi S., Kitamura K. Contraception in Japan: current trends. Contraception. 2016 Jun;93(6):475–7.
6. Gardiner D. Japan ok’s pill, cautiously. September 6, 1999. Available at: https://www.wired.com/1999/09/japan-oks-pill-cautiously/. Accessed May 22, 2019.
7. Zion Market Research. U.S. condom market size to reach USD 1,680.22 Mn by 2022. Global News Wire. January 10, 2018. Available at: https://www.globenewswire.com/news-release/2018/01/10/1286656/0/en/U-S-Condom-Market-Size-to-Reach-USD-1-680-22-Mn-by-2022-Zion-Market-Research.html. Accessed May 15, 2019.
8. Bill & Melinda Gates Foundation. Global Grand Challenges. Develop the next generation of condom. Available at: https://gcgh.grandchallenges.org/challenge/develop-next-generation-condom-round-12. Accessed May 15, 2019.
9. Salif Sow P., Ward S. Reinventing the condom. Impatient Optimists. Available at: https://www.impatientoptimists.org/Posts/2013/03/Reinventing-The-Condom#.XOXnHfZFw6Y. Accessed May 22, 2019.
10. Harrington E. Origami con man. Washington Beacon. May 1, 2014. Available at: https://freebeacon.com/issues/origami-con-man/. Accessed May 30, 2019.
11. Harrington E. Origami Condom inventor has to pay back taxpayer funds. Washington Beacon. May 1, 2014. https://freebeacon.com/issues/origami-condom-inventor-has-to-pay-back-taxpayer-funds/. Accessed May 30, 2019.
12. Taylor J. 2 years later, here’s what happened to Bill Gates’ condoms of the future. Mic. November 18, 2015. Available at: https://www.mic.com/articles/128850/bill-and-melinda-gates-foundation-condom-contest-where-are-they-now. Accessed June 1, 2019.
13. Kaler A. The female condom in North America: selling the technology of ‘empowerment.’ J Gend Stud. 2004;13(2):139–52. doi: 10.1080/0958923042000217819.
14. Anthes E. The future of sex? Mosaic. March 4, 2014. Available at: https://mosaicscience.com/story/future-sex/. Accessed May 30, 2019.
15. Guerrero D. Internal condoms become prescription only. Plus. June 6, 2017. https://www.hivplusmag.com/prevention/2017/6/16/internal-condoms-become-prescription-only. Accessed June 1, 2019.
16. Food and Drug Administration. Obstetrical and gynecological devices; reclassification of single-use female condom, to be renamed single-use internal condom. Federal Register. September 27, 2018. Available at: https://www.federalregister.gov/documents/2018/09/27/2018-21044/obstetrical-and-gynecological-devices-reclassification-of-single-use-female-condom-to-be-renamed. Accessed May 22, 2019.
17. Rogers K. Why are condoms still a thing? Vice. February 13, 2015. Available at: https://www.vice.com/enus/article/mgbx4x/why-are-condoms-still-a-thing. Accessed June 1, 2019.
18. Bolan R. K., Beymer M. R., Weiss R. E., Flynn R. P., Leibowitz A. A., Klausner J. D. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015 Feb;42(2):98–103.
19. Molina J. M., Charreau I., Chidiac C., Pialoux G., Cua E., Delaugerre C., Capitant C., Rojas-Castro D., Fonsart J., Bercot B., Bébéar C., Cotte L., Robineau O., Raffi F., Charbonneau P., Aslan A., Chas J., Niedbalski L., Spire B., Sagaon-Teyssier L., Carette D., Mestre S. L., Doré V., Meyer L.; ANRS IPERGAY Study Group. Postexposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308–17. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. PubMed PMID: 29229440.
20. Dubourg G., Raoult D. The challenges of preexposure prophylaxis for bacterial sexually transmitted infections. Clin Microbiol Infect. 2016 Sep;22(9):753–56. doi: 10.1016/j.cmi.2016.08.022. Epub 2016 Aug 29. Review. PubMed PMID: 27585939.
21. Fairley C.K., Chow EPF. Doxycycline postexposure prophylaxis: let the debate begin. Lancet Infect Dis. 2018 Mar;18(3):233–4.
22. Spinelli M. A., Scott H. M., Vittinghoff E., Liu A. Y., Coleman K., Buchbinder S. P. High interest in doxycycline for sexually transmitted infection postexposure prophylaxis in a multicity survey of men who have sex with men using a social networking application. Sex Transm Dis. 2019 Apr;46(4):e32–4.
23. Hook E. W. 3rd. 2008 Thomas Parran Award lecture. Translational research, STD control, and health disparities: a challenge and an opportunity. Sex Transm Dis. 2008 Dec;35(12):969–72.
24. Centers for Disease Control and Prevention. A Public Health Approach for Advancing Sexual Health in the United States: Rationale and Options for Implementation, Meeting Report of an External Consultation. Atlanta, GA: Centers for Disease Control and Prevention.
notes
Примечания
1
CDC (Centers for Disease Control and Prevention) – федеральное агентство министерства здравоохранения США, включает в себя около двух десятков учреждений с названиями, начинающимися с «Центр по…», поэтому агентство носит название «Центры…». – Прим. перев.
2
Заболевания, передающиеся половым путем (англ.).
3
Книга психиатра Дэвида Рубена (David Reuben).
4
Отсылка к роману американского писателя Натаниэля Готорна «Алая буква» (1850), одному из центральных произведений американской литературы. Пуританский роман, основными темами которого являются нетерпимость, грех и раскаяние, вызвал широкий резонанс как в Америке, так и в Европе. – Прим. перев.
5
HSV-2 (Herpes Simplex Virus) – вирус простого герпеса второго типа (англ.).
6
* Positive Singles, Meet People with Herpes, H-Date – «Одинокие люди с положительным анализом», «Знакомьтесь с людьми с герпесом», «Г (герпес) – свидания» (англ.).
7
STD Soulmates – «Вторая половинка с ЗППП» (англ.).
8
Аналогия с персонажем книги Доктора Сьюза – лесным духом Лораксом. – Прим. перев.
9
* По аналогии с главным девизом предвыборной кампании Дональда Трампа 2015–2016 годов «Сделаем Америку снова великой». – Прим. перев.
10
От сущ. vagina/penis (вагина/пенис) и гл. bedazzle (ослеплять блеском). – Прим. перев.
11
Хештег «Верните куст» (англ.).
12
* Термины «вагина» и «влагалище» – синонимы, оба слова означают расположенную в малом тазу мышечную трубку, соединяющую матку с вульвой. – Прим. перев.
13
Транскрипция weenie (сосиска, сленг. – «половой член»), записанная кириллицей. – Прим. перев.
14
Цитологический мазок – исследование, с помощью которого определяется наличие предраковых или раковых клеток во влагалище и шейке матки – также называют цервикальным мазком, а в англоязычных странах – мазком или тестом Папаниколау (Papanicolaou test, Pap test, Pap smear) по фамилии греческого ученого, пионера цитологии и ранней диагностики онкологических заболеваний Георгиоса Папаниколау. – Прим. перев.
